跳转至内容
Merck

D1507

Sigma-Aldrich

L -3,4-二羟基苯丙氨酸甲酯 盐酸盐

≥98% (HPLC), solid,  L-DOPA precursor

别名:

甲基 L -多巴 盐酸盐

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C10H13NO4 · HCl
CAS号:
分子量:
247.68
MDL號碼:
分類程式碼代碼:
12352209
eCl@ss:
32160406
PubChem物質ID:
NACRES:
NA.77

product name

L -3,4-二羟基苯丙氨酸甲酯 盐酸盐, solid

形狀

solid

品質等級

顏色

white to off-white

儲存溫度

−20°C

SMILES 字串

Cl[H].COC(=O)[C@@H](N)Cc1ccc(O)c(O)c1

InChI

1S/C10H13NO4.ClH/c1-15-10(14)7(11)4-6-2-3-8(12)9(13)5-6;/h2-3,5,7,12-13H,4,11H2,1H3;1H/t7-;/m0./s1

InChI 密鑰

WFGNJLMSYIJWII-FJXQXJEOSA-N

應用

L-3,4-二羟基苯丙氨酸甲酯盐酸盐用于:
  • 治疗6-羟基多巴胺诱导的小鼠5-羟色胺神经元损伤
  • 研究 B16F10 皮肤黑色素瘤细胞中酪氨酸酶活性
  • 研究其对中脑神经元的神经保护作用

生化/生理作用

L-3,4-二羟基苯丙氨酸甲酯是 L-DOPA 的前体,可穿过血脑屏障。抗帕金森氏病药物 L-DOPA 甲酯在白血病和黑色素瘤中引发抗肿瘤功能。

注意

光敏性

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Intranasal administration of the dopaminergic agonists L-DOPA, amphetamine, and cocaine increases dopamine activity in the neostriatum: a microdialysis study in the rat
De Souza Silva MA, et al.
Journal of Neurochemistry, 68(1), 233-239 (1997)
Sodium tanshinone IIA silate increases melanin synthesis by activating the MAPK and PKA pathways and protects melanocytes from H2 O2-induced oxidative stress
Zhong H, et al.
Royal Society of Chemistry Advances, 9(33), 18747-18757 (2019)
Fabrizio Stocchi et al.
Movement disorders : official journal of the Movement Disorder Society, 25(12), 1881-1887 (2010-07-30)
Melevodopa hydrochloride plus carbidopa in effervescent tablets (M/C) is a readily soluble antiparkinsonian tablet formulation. A total of 221 patients with Parkinson's disease and motor fluctuations entered a randomized, double-blind, double-dummy, controlled parallel group study, which compared the effectiveness of
3-O-Methyldopa inhibits astrocyte-mediated dopaminergic neuroprotective effects of l-DOPA
Asanuma M and Miyazaki I
BMC Neuroscience, 17(1), 52-52 (2016)
Xinxin Yang et al.
International journal of nanomedicine, 7, 2077-2086 (2012-05-24)
Levodopa remains the most effective drug in the treatment of Parkinson's disease. However, long-term administration of levodopa induces motor complications, such as levodopa-induced dyskinesia. The mechanisms underlying levodopa-induced dyskinesia are not fully understood. In this study, we prepared levodopa methyl

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门